10th ASM Conference on Candida and candidiasis

描述(由申请人提供)： = 注意：此摘要摘自应用程序，未经SRA校对。如果应用程序扫描过程有问题，提取的文本可能不正确或不完整。 = 念珠菌是人类的主要真菌病原体，可引起从口腔和阴道念珠菌病到危及生命的念珠菌症和侵袭性疾病的各种感染。念珠菌领域专注于与流行病学、耐药性、感染、宿主反应和治疗学相关的广泛主题。念珠菌和念珠菌病会议每两年举行一次，是介绍这些不同领域的前沿进展和最新观点的主要论坛。请求提供资金，为2010年3月22日至26日在佛罗里达州迈阿密举行的第十届念珠菌和念珠菌病会议提供部分支助。这次会议由美国微生物学会主办，该学会提供管理专业知识和资金支持。该计划基于该系列过去的会议，可靠地吸引了450多名美国和国际科学家参加，并在参与者调查中得到了热情的支持。我们的节目包括广度和及时性的临床演讲，演讲者经过精心筛选，以确保亲和力和有效性。我们还扩大了抗真菌耐药性和基因组测序工作的领域，以强调我们对生物体以及宿主-病原体相互作用的关键领域的最新进展。该计划将包括根据提交的摘要选择40名演讲者，提供展示尖端进展的灵活性，并招募新兴和成熟的社区成员作为演讲者。关于真菌疾病的遗传易感性、新技术、无脊椎动物模型系统和形态发生的同步讨论将进一步鼓励富有成效的互动和讨论。作为额外的好处，将在同一地点同时举行关于二相性真菌病原体的会议，并将与该会议分享一些念珠菌会议。我们有信心我们的目标--展示这一领域的最新进展、突出初级科学家的成就、促进协同和跨学科互动，以及提供一个供社区广泛讨论的场所--将会实现。公共卫生相关声明假丝酵母菌是引起传染病的主要真菌，影响艾滋病患者、癌症化疗患者、早产儿和许多其他人。第十届念珠菌和念珠菌病会议将为念珠菌研究界提供一个论坛，介绍最新的进展和想法，涵盖从临床问题到分子机制，从真菌的生长到宿主反应的广泛主题。这次会议将有助于规划未来研究的进程，促进了解、治疗和预防疾病的迫切需要。

DESCRIPTION (provided by applicant): ================== NOTICE: THIS ABSTRACT WAS EXTRACTED FROM APPLICATION AND HAS NOT BEEN PROOFED BY AN SRA.WHEN THERE ARE PROBLEMS WITH THE APPLICATION SCANNING PROCESS, THE EXTRACTED TEXT MAY BE INCORRECT OR INCOMPLETE. ================== Candida is the major fungal pathogen of humans, causing infections that range from oral and vaginal candidiasis to life-threatening candidemia and invasive disease. The Candida field focuses on a broad spectrum of subjects that relate to epidemiology, drug resistance, infection, host response, and therapeutics. The Candida and Candidiasis Conference, held every two years, is the premier forum for presentation of cutting-edge advances and the latest perspectives in these diverse areas. Funds are requested to provide partial support for the 10th Conference on Candida and Candidiasis, which will be held from March 22-26, 2010, in Miami, FL. The conference is sponsored by the American Society for Microbiology, which provides both management expertise and financial support. The program is based upon past conferences of the series, which have reliably drawn attendance of over 450 American and International scientists, and have met with enthusiastic support in participant surveys. Our program includes clinical talks of breadth and timeliness, with speakers carefully prescreened for affability and effectiveness. We have also expanded the areas of antifungal resistance and genome sequencing efforts to emphasize recent advances in our understanding of the organism as well as the key area of host-pathogen interaction. The program will include selection of 40 speakers based on submitted abstracts, providing the flexibility to present cutting- edge advances and to enlist emerging as well as established community members as speakers. A set evening concurrent discussion sessions on genetic susceptibility to fungal disease, new technologies, invertebrate model systems and morphogenesis will further encourage productive interaction and discussion. As an added bonus, a meeting on Dimorphic Fungal Pathogens will be held in parallel at the same site and a few of the Candida conference sessions will be shared with that meeting. We are confident that our goals - to present the latest advances in the field, to spotlight achievements of junior scientists, to promote synergistic and interdisciplinary interactions, and to provide a venue for community-wide discussion - will be achieved. Public Health Relevance Statement Candida is the major fungus that causes infectious disease, affecting AIDS patients, cancer chemotherapy patients, premature infants, and many others. The 10th Conference on Candida and Candidiasis will provide a forum for the Candida research community to present the most recent advances and ideas, covering a broad spectrum of subjects from clinical issues to molecular mechanisms, from growth of the fungus to response of the host. The conference will help chart the course of future research and facilitate the urgent necessity to understand, treat, and prevent disease.